Dieter Dorsch

1.6k total citations
40 papers, 950 citations indexed

About

Dieter Dorsch is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Dieter Dorsch has authored 40 papers receiving a total of 950 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Organic Chemistry and 7 papers in Physiology. Recurrent topics in Dieter Dorsch's work include Nitric Oxide and Endothelin Effects (7 papers), Receptor Mechanisms and Signaling (6 papers) and Liver physiology and pathology (5 papers). Dieter Dorsch is often cited by papers focused on Nitric Oxide and Endothelin Effects (7 papers), Receptor Mechanisms and Signaling (6 papers) and Liver physiology and pathology (5 papers). Dieter Dorsch collaborates with scholars based in Germany, Italy and Australia. Dieter Dorsch's co-authors include Werner W. K. R. Mederski, Claudia Wilm, Soheila Anzali, Ulrich Grädler, G. Marowsky, R. Steinhoff, Frank Stieber, Andree Blaukat, Manja Friese‐Hamim and Michael Meyring and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Clinical Cancer Research.

In The Last Decade

Dieter Dorsch

40 papers receiving 918 citations

Peers

Dieter Dorsch
William C. Lumma United States
Paul W. Baures United States
Alfred P. Spada United States
Kenji Morikami United States
Nina C. Gonnella United States
Katrin Spiegel United States
Shunqi Yan United States
Dieter Dorsch
Citations per year, relative to Dieter Dorsch Dieter Dorsch (= 1×) peers Christoph Niederalt

Countries citing papers authored by Dieter Dorsch

Since Specialization
Citations

This map shows the geographic impact of Dieter Dorsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dieter Dorsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dieter Dorsch more than expected).

Fields of papers citing papers by Dieter Dorsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dieter Dorsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dieter Dorsch. The network helps show where Dieter Dorsch may publish in the future.

Co-authorship network of co-authors of Dieter Dorsch

This figure shows the co-authorship network connecting the top 25 collaborators of Dieter Dorsch. A scholar is included among the top collaborators of Dieter Dorsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dieter Dorsch. Dieter Dorsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Esdar, Christina, Nina Linde, Andreas Blum, et al.. (2025). M4205 (IDRX-42) Is a Highly Selective and Potent Inhibitor of Relevant Oncogenic Driver and Resistance Variants of KIT in Cancer. Molecular Cancer Therapeutics. 24(7). 1040–1053. 1 indexed citations
2.
Merkul, Eugen, Thomas J. J. Müller, Christina Esdar, et al.. (2016). Discovery of novel 7-azaindoles as PDK1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(13). 3073–3080. 16 indexed citations
3.
Dorsch, Dieter, Oliver Schadt, Frank Stieber, et al.. (2015). Identification and optimization of pyridazinones as potent and selective c-Met kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(7). 1597–1602. 68 indexed citations
4.
Bladt, Friedhelm, Manja Friese‐Hamim, Christine Knuehl, et al.. (2013). EMD 1214063 and EMD 1204831 Constitute a New Class of Potent and Highly Selective c-Met Inhibitors. Clinical Cancer Research. 19(11). 2941–2951. 114 indexed citations
5.
Merkul, Eugen, et al.. (2011). Rapid preparation of triazolyl substituted NH-heterocyclic kinase inhibitors via one-pot Sonogashira coupling–TMS-deprotection–CuAAC sequence. Organic & Biomolecular Chemistry. 9(14). 5129–5129. 33 indexed citations
6.
Bladt, Friedhelm, Andree Blaukat, Dieter Dorsch, et al.. (2010). Abstract 3622: Preclinical characterization of EMD1214063, a potent and highly selective inhibitor of the c-Met kinase in Phase I clinical trials. Cancer Research. 70(8_Supplement). 3622–3622. 4 indexed citations
7.
Mederski, Werner W. K. R., et al.. (2004). Chlorothiophenecarboxamides as P1 surrogates of inhibitors of blood coagulation factor Xa. Bioorganic & Medicinal Chemistry Letters. 14(23). 5817–5822. 17 indexed citations
8.
Mederski, Werner W. K. R., et al.. (2004). Halothiophene benzimidazoles as P1 surrogates of inhibitors of blood coagulation factor Xa. Bioorganic & Medicinal Chemistry Letters. 14(14). 3763–3769. 75 indexed citations
9.
Koert, Ulrich, et al.. (2004). Dianhydrohexitole-Based Benzamidines: An Efficient Synthesis of New Factor Xa Inhibitors. Synthesis. 2004(8). 1211–1228. 4 indexed citations
10.
Stubbs, Milton T., et al.. (2002). pH‐Dependent Binding Modes Observed in Trypsin Crystals: Lessons for Structure‐Based Drug Design. ChemBioChem. 3(2-3). 246–249. 65 indexed citations
11.
Mederski, Werner W. K. R., et al.. (1999). Benzofuro[3,2-b]pyridines as mixed and selective ETB endothelin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 9(4). 619–622. 30 indexed citations
12.
Mederski, Werner W. K. R., Dieter Dorsch, Soheila Anzali, et al.. (1998). 3. Endothelin antagonists: discovery of EMD 122946, a highly potent and orally active ETA selective antagonist. Bioorganic & Medicinal Chemistry Letters. 8(13). 1771–1776. 9 indexed citations
13.
Mederski, Werner W. K. R., et al.. (1998). 2.Endothelin antagonists: Evaluation of 2,1,3-benzothiadiazole as a methylendioxyphenyl bioisoster. Bioorganic & Medicinal Chemistry Letters. 8(1). 17–22. 16 indexed citations
14.
Anzali, Soheila, et al.. (1998). 1. Endothelin antagonists: Search for surrogates of methylendioxyphenyl by means of a kohonen neural network. Bioorganic & Medicinal Chemistry Letters. 8(1). 11–16. 29 indexed citations
15.
Mederski, Werner W. K. R., et al.. (1997). 1,4-Diaryl-2-oxo-1,2-dihydro-quinoline-3-carboxylic acids as endothelin receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 7(14). 1883–1886. 35 indexed citations
16.
Mederski, Werner W. K. R., et al.. (1994). Non-Peptide Angiotensin II Receptor Antagonists: Synthesis and Biological Activity of a Series of Novel 4,5-Dihydro-4-oxo-3H-imidazo[4,5-c]pyridine Derivatives. Journal of Medicinal Chemistry. 37(11). 1632–1645. 20 indexed citations
17.
Reißig, Hans‐Ulrich, et al.. (1994). Stereoselective synthesis of (2S,3S)‐norstatine derivatives by addition of lithiated methoxyallene to amino aldehydes and subsequent ozonolysis. Liebigs Annalen der Chemie. 1994(2). 121–127. 19 indexed citations
18.
Reißig, Hans‐Ulrich, et al.. (1993). Titanated Methoxyallene as Novel Homoaldol Equivalent for Diastereoselective Additions to Chiral Amino Aldehydes. Angewandte Chemie International Edition in English. 32(10). 1449–1450. 15 indexed citations
19.
Marowsky, G., et al.. (1988). Non-linear optical properties of hemicyanine monolayers and the protonation effect. Chemical Physics Letters. 147(5). 420–424. 93 indexed citations
20.
Selim, Abdulhafez, et al.. (1983). Influence of cation complexing solvent additives and functional groups in asymmetric alkylations of esters via lithium enolates. Tetrahedron Letters. 24(31). 3213–3216. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026